Eckert & Ziegler Strahlen- und Medizintechnik AG Logo

Eckert & Ziegler Strahlen- und Medizintechnik AG

A global provider of isotope technology for medical, scientific, and industrial use.

EUZ | F

Overview

Corporate Details

ISIN(s):
DE0005659700
LEI:
391200EUDABLUKXCKG48
Country:
Germany
Address:
Robert-Rössle-Str. 10, 13125 Berlin

Description

Eckert & Ziegler Strahlen- und Medizintechnik AG is a global provider of isotope technology for medical, scientific, and industrial use. The company's core business focuses on cancer therapy, industrial radiometry, and nuclear-medical imaging. It specializes in developing and manufacturing radioactive components and related equipment. Key offerings for the medical sector include products and services for nuclear medicine and radiation therapy, such as radiopharmaceuticals, radiosynthesis and quality control (QC) solutions, and sealed radiation sources. The company also provides essential infrastructure like hot cells and radiation protection solutions, supporting the radiopharmaceutical industry from early development through to commercial production.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2005-03-02 16:29
Eckert & Ziegler AG Acquires Majority in Berlin Cyclotron Company
English HTML 3.6 KB
2005-02-02 09:24
Eckert & Ziegler: Strong Growth in the Fiscal Year 2004
English HTML 2.1 KB
2004-12-15 12:35
Eckert & Ziegler: Breakthrough on reimbursement in France
English HTML 3.3 KB
2004-12-09 10:10
Eckert & Ziegler AG expands Supervisory Board
English HTML 2.7 KB
2004-11-09 07:45
Eckert & Ziegler: 42% Sales Increase in Third Quarter. Strong Growth in the ...
English HTML 2.1 KB
2004-08-10 07:40
Eckert & Ziegler: strong sales and increased profits in the 1st half of 2004
English HTML 2.0 KB
2004-06-16 07:54
Eckert & Ziegler Strengthens Core Business
English HTML 2.2 KB
2004-05-11 07:48
Eckert & Ziegler: 17% Sales Increase in First Quarter
English HTML 1.9 KB
2004-03-29 07:45
Eckert & Ziegler: Clear improvement in net income with sales unchanged
English HTML 2.1 KB
2004-03-16 10:40
Eckert & Ziegler to Acquire Radiation Product Business of HEK GmbH
English HTML 2.2 KB
2004-03-04 10:24
Eckert & Ziegler Acquires a Majority Stake in Sales Subsidiary
English HTML 1.7 KB
2004-02-19 11:59
Eckert & Ziegler: Result Increased, Sales Volume Stable
English HTML 2.0 KB
2004-02-17 12:06
Change in the Supervisory Board of Eckert & Ziegler
English HTML 2.0 KB
2003-11-21 09:17
Eckert & Ziegler to Acquire CIS bio Afterloader Business
English HTML 2.4 KB
2003-11-11 07:45
Eckert & Ziegler AG english
English HTML 2.3 KB

Automate Your Workflow. Get a real-time feed of all Eckert & Ziegler Strahlen- und Medizintechnik AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eckert & Ziegler Strahlen- und Medizintechnik AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eckert & Ziegler Strahlen- und Medizintechnik AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-08-30 Eckert, Dr. Andreas Supervisory board Sell None 1,526,400.00 EUR
2023-08-30 Eckert Wagniskapital und Frühphasenfinanzierung GmbH Close relation Buy None 1,526,400.00 EUR
2023-08-11 Perschmann, Frank Supervisory board Buy None 16,600.00 EUR
2023-01-13 NEON Equity AG Close relation Buy None 2,115.00 EUR
2023-01-12 Blunck, Dr. Thomas Board Sell None 57,402.00 EUR
2023-01-12 Blunck, Dr. Thomas Board Sell None 32,160.00 EUR
2023-01-11 Bouterfa, Dr. Hakim Board Buy None 124,800.00 EUR
2022-12-21 Eckert Wagniskapital und Frühphasenfinanzierung GmbH Close relation Buy None 1,432,800.00 EUR
2022-12-06 Maennig, Prof. Dr. Wolfgang Supervisory board Buy None 72,745.31 EUR
2022-12-05 Carpio GmbH Close relation Buy None 73,826.53 EUR

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.